D64.1
Secondary sideroblastic anemia due to disease
Clinical Classification Guidelines
Code First
- underlying disease
Medical Intelligence & Overview
Secondary sideroblastic anemia due to disease (ICD-10 Code D64.1) is a form of anemia characterized by the presence of abnormal red blood cell precursors called sideroblasts in the bone marrow. Unlike primary sideroblastic anemia, which occurs due to intrinsic problems in the blood-making process, secondary sideroblastic anemia develops as a result of another underlying disease or condition. This type of anemia impacts the body's ability to produce healthy red blood cells, leading to symptoms associated with reduced oxygen delivery throughout the body.
Causes & Symptoms
Clinical Causes: S e c o n d a r y s i d e r o b l a s t i c a n e m i a i s n o t i n h e r i t e d b u t i s c a u s e d b y o t h e r h e a l t h i s s u e s o r e x p o s u r e s , i n c l u d i n g : - C h r o n i c i n f l a m m a t o r y d i s e a s e s - C e r t a i n i n f e c t i o n s - E x p o s u r e t o t o x i n s o r d r u g s s u c h a s c h l o r a m p h e n i c o l o r l i n e z o l i d - A l c o h o l a b u s e - C o p p e r d e f i c i e n c y - M y e l o d y s p l a s t i c s y n d r o m e s - O t h e r h e m a t o l o g i c m a l i g n a n c i e s o r c h r o n i c i l l n e s s e s t h a t i n t e r f e r e w i t h n o r m a l b l o o d c e l l p r o d u c t i o n
Key Symptoms: I n d i v i d u a l s w i t h s e c o n d a r y s i d e r o b l a s t i c a n e m i a m a y e x p e r i e n c e s y m p t o m s t h a t r e f l e c t r e d u c e d o x y g e n s u p p l y a n d a n e m i a . T h e s e i n c l u d e : - F a t i g u e a n d w e a k n e s s - P a l e s k i n a n d m u c o u s m e m b r a n e s - S h o r t n e s s o f b r e a t h , e s p e c i a l l y d u r i n g p h y s i c a l a c t i v i t y - R a p i d o r i r r e g u l a r h e a r t b e a t - D i z z i n e s s o r l i g h t h e a d e d n e s s - H e a d a c h e s - C o l d h a n d s a n d f e e t - P o s s i b l e s i g n s o f a n u n d e r l y i n g c o n d i t i o n c a u s i n g t h e a n e m i a , s u c h a s w e i g h t l o s s o r f e v e r , d e p e n d i n g o n t h e a s s o c i a t e d d i s e a s e
Diagnostic & Treatment
Diagnosis Path: Diagnosing secondary sideroblastic anemia involves a combination of blood tests, bone marrow examination, and medical history review: - Complete blood count (CBC) to assess red blood cell levels, hemoglobin, and hematocrit. - Blood smear to evaluate red blood cell size and shape. - Iron studies to measure serum iron, ferritin, and transferrin saturation. - Bone marrow biopsy and aspirate to identify the presence of ring sideroblasts, which are abnormal nucleated red blood cell precursors. - Tests to identify underlying diseases, such as infection screening, autoimmune markers, or assessments for chronic illnesses. - Genetic testing may be considered in some cases, especially if inherited conditions are suspected.
Treatment Protocols: Managing secondary sideroblastic anemia focuses on treating the underlying condition and alleviating anemia symptoms: - Addressing the root cause, such as controlling infections or managing chronic illnesses. - Iron chelation therapy if iron overload occurs. - Blood transfusions may be necessary to manage severe anemia. - Supplementation with vitamins like B6 (pyridoxine), which can be effective when deficiencies are involved. - Discontinuing or substituting offending medications that may contribute to the condition. - Close monitoring of blood counts and response to therapy. - In some cases, erythropoietic agents or other medications may be used to stimulate red blood cell production. - Regular follow-up to assess the progression or resolution of the anemia and related health issues.
Clinical Advice & FAQs
Billing Guidance
Is D64.1 a billable ICD-10 code?
Yes, D64.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D64.1?
Clinical documentation must specify the nature of Secondary sideroblastic anemia due to disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
